Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis

Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis

Background Hyperphosphatemia occurs universally in end-stage renal disease(ESRD), and the attainment of target serum phosphate levels remains suboptimal with currently available phosphate binders. This meta-analysis aimed to evaluate the efficacy and safety of tenapanor in end-stage renal disease pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Shanshen Yu, Jia Sun, Xiafei Guo
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Tenapanor
end-stage renal disease
hyperphosphatemia
meta-analysis
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2410389
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items